Acute Management
Parenteral, weight-adjusted anticoagulation should be used:
- Low-molecular weight heparin (LMWH) SC 1
- Fondaparinux SC 1
- Unfractionated heparin (UFH) IV 1
- Generally second line due to higher bleeding risk and HIT risk
- Preferred agent in the setting of:
- Overt haemodynamic instability or imminent haemodynamic decompensation in whom primary reperfusion treatment will be necessary (short half life and easy reversal)
- Increased risk of bleeding
- Serious renal impairment (creatinine clearance <30 mL/min)
Longer-Term Management
Started when the patient's condition is stable and no invasive procedures are planned
- Non-vitamin K oral anticoagulant (NOAC)
- Warfarin international normalized ratio (INR) is 2.0 to 3.0: